Latest News

Ultragenyx Pharmaceutical (RARE) is back in focus after releasing long term UX111 gene therapy data in Sanfilippo syndrome type A. This is tied directly to a fresh FDA BLA resubmission that follows earlier clinical and legal setbacks. See our latest analysis for Ultragenyx Pharmaceutical. Against this backdrop, Ultragenyx’s 1-day share price return of a 1.32% decline and 7-day share price return of a 3.28% decline sit alongside a 90-day share price return of a 27.42% decline and a 1-year...

If you are wondering whether BlackRock’s current share price lines up with its underlying worth, you are not alone. That is exactly what this article is here to unpack. Over the past year, the stock has returned 13.5%, with a 0.6% gain over the last 7 days, a 0.6% decline over 30 days, and a 0.2% decline year to date from a last close of US$1,082.88. Recent coverage has centered on BlackRock’s role as one of the largest global asset managers and its position in long term investment themes,...

Earnings event puts ShinMaywa Industries (TSE:7224) in focus ShinMaywa Industries (TSE:7224) has drawn fresh attention after reporting nine month earnings to December 31, 2025, with sales of ¥195,739 million and net income of ¥6,339 million. Basic earnings per share from continuing operations for the period were ¥95.87, compared with ¥74.68 a year earlier, giving investors an updated snapshot of how the business is performing across its core operations. See our latest analysis for ShinMaywa...

If you are wondering whether Noble's current share price lines up with its underlying worth, you are not alone. This article is here to unpack that question clearly. Noble's share price recently closed at US$44.06, with returns of 14.5% over 7 days, 47.3% over 30 days, 51.9% year to date, and 55.6% over 1 year, which has caught the attention of many investors thinking about growth potential and changing risk perceptions. Recent coverage of Noble has highlighted the stock's role in the energy...

Pegasystems (PEGA) capped FY 2025 with fourth quarter revenue of US$504.3 million and basic EPS of US$1.38, alongside trailing twelve month revenue of US$1.75 billion and EPS of US$2.30, set against earnings growth of 296.7% over the past year. Over recent periods, the company has seen quarterly revenue move between US$325.1 million and US$504.3 million and basic EPS range from a loss of US$0.08 to a gain of US$1.38, while trailing net profit margin increased from 6.6% to 22.5%. For...

If you are wondering whether Twilio’s current share price lines up with its underlying worth, you are not alone. This article is here to unpack the numbers in a clear, practical way. Twilio’s stock closed at US$110.44, with returns of a 1.3% decline over 7 days, a 16.3% decline over 30 days, a 20.2% decline year to date, a 23.6% decline over 1 year and a 67.2% gain over 3 years, alongside a 73.2% decline over 5 years. Taken together, these figures suggest investors have been repeatedly...

If you are looking at CK Hutchison Holdings and wondering whether its current share price offers good value, it helps to first step back and frame what "value" really means for this business. The stock recently closed at HK$63.50, with returns of 7.3% over 30 days, 17.6% year to date, 68.9% over 1 year, 56.8% over 3 years and 49.4% over 5 years. These figures will shape how many investors are now thinking about both upside and risk. Recent news flow around CK Hutchison Holdings has focused...

If you are trying to figure out whether AST SpaceMobile is priced attractively or already baking in big expectations, you are in the right place for a clear look at its valuation. The share price recently closed at US$96.92, with returns of 16.1% year to date and 251.0% over the last year, even after a 6.4% decline over the past week and a 1.5% decline over the last month. Recent news has focused on AST SpaceMobile's efforts to build a space based cellular broadband network, along with...

MoonLake Immunotherapeutics: Recent Returns Put Volatility in Focus MoonLake Immunotherapeutics (MLTX) has seen mixed share performance recently, with a 1 day return of 1.1%, a 7 day gain of 5.1%, a month decline of 12.7%, and a past 3 months gain of 25.7%. See our latest analysis for MoonLake Immunotherapeutics. At a share price of $15.79, MoonLake Immunotherapeutics has paired strong recent share price momentum, with a 90 day share price return of 25.7% and a year to date share price return...

Altus Group (TSX:AIF) has been under pressure after its latest earnings report, where management flagged weaker transaction-related revenues and trimmed near term growth expectations, despite continued investment in cloud-based data and analytics platforms. See our latest analysis for Altus Group. Those earnings comments have clearly fed into trading, with Altus Group’s 30 day share price return of -26.7% and year to date share price return of -27.0% both firmly negative, while the 1 year...

If you are wondering whether D-Wave Quantum's share price still lines up with its underlying worth, this article will help you weigh what you are really paying for. The stock closed at US$19.64, with a 7 day return of a 2.3% decline, a 30 day return of a 31.8% decline and a year to date return of a 30.2% decline, set against a 1 year return of 225.2% and a very large 3 year gain. Recent coverage around D-Wave Quantum has focused on its position in quantum computing and how investors are...

Event context and recent share performance Cincinnati Financial (CINF) has been drawing attention after a period of mixed short term returns, with a slight gain over the past month, a small decline over the past 3 months, and a stronger 1 year total return. See our latest analysis for Cincinnati Financial. With the share price at US$163.46, Cincinnati Financial’s recent 7 day share price return of a 4.7% decline contrasts with its 1 year total shareholder return of about 21.9%, hinting that...

Kourakuen (TSE:7554) has just wrapped up its Q3 2025 reporting window, with recent quarters showing Total Revenue in the ¥6.5b to ¥7.1b range and Basic EPS between roughly ¥7.1 and ¥25.0, capped by Q1 2026 revenue of ¥6,909.7 million and EPS of ¥7.06. Over the past few periods, the company has reported revenue of ¥6,847 million in Q3 2024, ¥6,890 million in Q4 2024, ¥6,582 million in Q1 2025, and ¥7,131 million in Q2 2025. EPS over the same periods came in at ¥10.56, ¥11.51, ¥7.57, and...

KeyCorp (NYSE:KEY) and HoldCo Asset Management agreed to halt acquisitions, initiate a US$300 million stock buyback, and add a new independent director. The agreement heads off a potential proxy fight and reflects active engagement between the bank and one of its shareholders. KeyCorp is a regional banking group focused on lending, deposit gathering, and related financial services, an area that has been under close investor scrutiny after industry stresses and tighter regulation...

Devon Energy and Coterra Energy (NYSE:CTRA) have entered into a definitive merger agreement, forming a combined shale operator with an estimated enterprise value of about US$58b. The deal includes changes to the management team and board structure for the combined company. The transaction terms feature higher dividends for shareholders and a sizeable share repurchase program. An investigation is underway into whether Coterra's Board met its fiduciary duties in agreeing to the...

Textron’s new buyback and board appointment in focus Textron (TXT) has drawn fresh attention after its Board authorized a new share repurchase program for up to 25,000,000 shares, alongside the upcoming addition of finance veteran Cristina Méndez to its Board of Directors. See our latest analysis for Textron. At a share price of $97.28, Textron has seen a 7.22% 7 day share price return and an 11.75% year to date share price return. Its 1 year total shareholder return of 33.76% and 5 year...

Earlier in February 2026, Kratos Defense & Security Solutions announced its selection for Phase 1 of the U.S. Office of the Secretary of War’s Drone Dominance Gauntlet, alongside new contracts of about US$65,000,000 for training simulators and progress on its Mighty Hornet IV attack UAV collaboration with Taiwan’s NCSIST. These developments highlight how Kratos is increasingly embedded in next‑generation unmanned systems programs, potentially reinforcing its position in low-cost, high-volume...

If you are wondering whether Copart's current share price really matches its underlying worth, you are not alone. That is exactly what this article will help you unpack. Over the past year the stock is down 33.1%, even though it is up 4.6% year to date. This can change how investors think about both its growth potential and its risk profile. Recent headlines around Copart have focused on its role in vehicle remarketing and salvage auctions, as investors watch how demand for used and damaged...

Meren Energy (TSX:MER) is back on investors' radar after announcing that long serving CEO and President Dr. Roger Tucker has stepped down. Dr. Oliver Quinn will assume both leadership roles from February 2, 2026. See our latest analysis for Meren Energy. Meren Energy’s leadership handover comes as the stock trades at CA$2.24, with a 1 day share price return of 9.8% and a 30 day share price return of 21.08% pointing to building short term momentum. The 5 year total shareholder return of...

Strategy, listed as NasdaqGS:MSTR, has launched and expanded a perpetual preferred stock program branded "Stretch" to fund additional Bitcoin acquisitions. The company is using Stretch to raise capital for its Bitcoin strategy while aiming to limit dilution from new common share issuances. The preferred structure introduces fixed dividend obligations that could reshape Strategy's capital mix and risk profile over time. Strategy, trading at $126.07, sits at the intersection of AI analytics...

The UK market has recently faced challenges, with the FTSE 100 and FTSE 250 indices experiencing declines amid weak trade data from China, highlighting ongoing global economic uncertainties. In such a climate, investors often seek opportunities in less conventional areas of the market. Penny stocks, despite their somewhat outdated moniker, continue to attract attention for their potential to offer value and growth when backed by strong financials.

Nektar Therapeutics ( NASDAQ:NKTR ) shares have had a really impressive month, gaining 81% after a shaky period...

Hargreaves Services Plc ( LON:HSP ) has announced that it will be increasing its dividend from last year's comparable...

The board of Community Financial System, Inc. ( NYSE:CBU ) has announced that it will pay a dividend of $0.47 per share...